NAS:ALBO (USA) Also Trade In: Germany

Albireo Pharma Inc $ 32.60 -0.32 (-0.97%)

Volume:
100,025
Avg Vol (1m):
160,557
Market Cap $:
623.10 Mil
Enterprise Value $:
381.45 Mil
PE Ratio:
0.00
PB Ratio:
3.44
Warning! GuruFocus has detected 1 Severe warning sign with ALBO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Albireo Pharma Inc () from 2007 to Apr 17 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Albireo Pharma stock (ALBO) PE ratio as of Apr 17 2021 is 0. More Details

Albireo Pharma PE Ratio (TTM) Chart

EMBED

Albireo Pharma PE Ratio (TTM) Historical Data

Total 1210
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Albireo Pharma PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-04-170.0 2021-02-150.0
2021-04-160.0 2021-02-120.0
2021-04-150.0 2021-02-110.0
2021-04-140.0 2021-02-100.0
2021-04-130.0 2021-02-090.0
2021-04-120.0 2021-02-080.0
2021-04-090.0 2021-02-050.0
2021-04-080.0 2021-02-040.0
2021-04-070.0 2021-02-030.0
2021-04-060.0 2021-02-020.0
2021-04-050.0 2021-02-010.0
2021-04-020.0 2021-01-290.0
2021-04-010.0 2021-01-280.0
2021-03-310.0 2021-01-270.0
2021-03-300.0 2021-01-260.0
2021-03-290.0 2021-01-250.0
2021-03-260.0 2021-01-220.0
2021-03-250.0 2021-01-210.0
2021-03-240.0 2021-01-200.0
2021-03-230.0 2021-01-190.0
2021-03-220.0 2021-01-150.0
2021-03-190.0 2021-01-140.0
2021-03-180.0 2021-01-130.0
2021-03-170.0 2021-01-120.0
2021-03-160.0 2021-01-110.0
2021-03-150.0 2021-01-080.0
2021-03-120.0 2021-01-070.0
2021-03-110.0 2021-01-060.0
2021-03-100.0 2021-01-050.0
2021-03-090.0 2021-01-040.0
2021-03-080.0 2020-12-310.0
2021-03-050.0 2020-12-300.0
2021-03-040.0 2020-12-290.0
2021-03-030.0 2020-12-280.0
2021-03-020.0 2020-12-240.0
2021-03-010.0 2020-12-230.0
2021-02-260.0 2020-12-220.0
2021-02-250.0 2020-12-210.0
2021-02-240.0 2020-12-180.0
2021-02-230.0 2020-12-170.0
2021-02-220.0 2020-12-160.0
2021-02-190.0 2020-12-150.0
2021-02-180.0 2020-12-140.0
2021-02-170.0 2020-12-110.0
2021-02-160.0 2020-12-100.0

Albireo Pharma PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry
Healthcare » Biotechnology » NAICS : 325412 NAICS : 2834
Traded in other countries
Address
10 Post Office Square, Suite 502, South Boston, MA, USA, 02109
Albireo Pharma Inc is a biopharmaceutical company. It engages in the research and development of drug reformulation technology. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal.